Finland · Medical Device

Revenio

Revenio provides enterprise-scale e-marketing software to capture customer attention, loyalty and value.

PrivateFor profit

Medical DeviceVantaa, Southern Finland, Finland

Why reach out now

What the record says about Revenio as a customer or partner.

Against its peers

Set against 62 Medical Device companies in Finland. The ring marks the typical peer.

LinkedIn followers2k#22 of 61; the typical peer has 612
Staff11-50The typical size for its peers
Founded19993 years before the typical peer (2002)
Website traffic#7.8MQuieter than the typical peer's site (#4.9M)

Across all 5.9M companies: larger than 33% of those with a size listed; older than 68% of those with a founding year; website ranked #7,774,288 in the world, about 716 visits a month. 31 people list it on LinkedIn, and 2,084 follow it.

About Revenio

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2024, the Group’s net sales totaled EUR 103.5 million, with an operating profit of EUR 25.0… Read all

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2024, the Group’s net sales totaled EUR 103.5 million, with an operating profit of EUR 25.0 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V. Revenio on kansainvälisillä markkinoilla toimiva kokonaisvaltaisten silmien hoidon diagnostiikkaratkaisuiden toimittaja. Konserni tarjoaa nopeita, helppokäyttöisiä ja luotettavia työkaluja glaukooman, diabeettisen retinopatian ja silmänpohjan rappeuman diagnosointiin. Revenio-konsernin silmän diagnostiikkaratkaisuihin kuuluvat iCare-brändin alla silmänpaineen mittauslaitteet (tonometrit), silmänpohjan kuvantamislaitteet, perimetrit ja ohjelmistoratkaisut. Revenio-konsernin liikevaihto vuonna 2024 oli 103,5 miljoonaa euroa ja liiketulos 25,0 miljoonaa euroa. Revenio Group Oyj:n osake on listattu Nasdaq Helsinki Oy:ssä kaupankäyntitunnuksella REG1V.

What it does

InternetMarketingSoftware

Funding, as listed

What the source datasets report. We have not watched these rounds ourselves.

$16M

raised in total across 1 round

Last raised Mar 2000, 26 years ago

Rounds
1
Latest round
Series unknown
Latest amount
$16M
Investors
21 leading

Corporate family

Where it sits in its group, and the deals it has done.

This companyRevenio1acquisition made

Key facts

Who started it and how it trades.

Founded by
Andy Payne

Every detail we hold

Everything the source datasets list about Revenio, field by field. Contact details are held but never shown.

The company7 fields

Name
Revenio
Type
For profit
Status
Private
Founded
1999
Founders
Andy Payne
Industry
Medical Device
Categories
Internet, Marketing, Software

Where4 fields

City
Vantaa
Region
Southern Finland
Country
Finland
Markets
Greater Boston Area, East Coast, New England, Northeastern US

Size and reach5 fields

Staff band
11-50
People on LinkedIn
31
LinkedIn followers
2,084
Web traffic rank
#7,774,288
Monthly web visits
716
Show 11 more fieldsShow fewer fields

Funding, as listed8 fields

Total
$16,000,000 USD
Rounds
1
Latest round
Series unknown
Latest round date
Mar 2000
Latest amount
16,000,000 USD
Investors
2
Lead investors
1
Listing status
private

Corporate family1 field

Acquisitions made
1

About this record2 fields

Sources
Crunchbase, LinkedIn
Last imported
Sept 2026

Growth, as the source summarises it

Revenio Group Oyj may be growing as the company has surpassed full-year earnings expectations for 2023, which is a strong indicator of financial performance and often reflects increased revenue and profitability. Analysts have also provided a valuation for the company's shares post-results, suggesting a recognition of the company's value in the market following its financial achievements. Furthermore, the concern about the company's debt usage implies that Revenio Group Oyj is being scrutinized for its financial strategies, which often occurs when a company is expanding and investing.

Companies like Revenio

Medical Device in Finland.

Build a lead list

62 Medical Device companies in Finland, filtered by size, age and reach, ready to export with emails on Pro.

Open the list